Trial reportClinical drug investigation2006
Safety of oral ibandronate in the treatment of bone metastases from breast cancer : long-term follow-up experience.
Trial report in Clinical drug investigation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Pooled it
- Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directions.Frontiers in oncology · 2026Review
- Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis.Heliyon · 2024Review
- The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis.Therapeutic advances in medical oncology · 2019Article
- National consensus in China on diagnosis and treatment of patients with advanced breast cancer.Annals of translational medicine · 2015Review
- Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.BMC cancer · 2015Review
- Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.Therapeutics and clinical risk management · 2008Article
- Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.Drugs · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.